What We're Reading: Page 204
Industry reads hand-picked by our editors
Feb 10, 2020
-
The New York Times
China's Lavish Funds Lured U.S. Scientists. What Did It Get in Return?
-
Financial Times
The onetime Parisian street fighter who gave his company purpose
-
The Wall Street Journal
Pharma Megadeals Pass First Checkup
Feb 07, 2020
-
The Wall Street Journal
Where Are All the Women CEOs?
-
STAT
Lottery like no other offers a cutting-edge medicine — with lives on the line
-
The Washington Post
Doctor’s death from coronavirus sparks a digital uprising, rattling China’s leaders
-
Forbes
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
Feb 06, 2020
Feb 05, 2020
Feb 04, 2020
Feb 03, 2020
Jan 31, 2020
-
The New York Times
How Chaos at Chain Pharmacies Is Putting Patients at Risk
-
In the Pipeline
Another AI-Generated Drug?
-
STAT
U.S. officials will let Novartis pay expenses for some Kymriah patients
-
Regulatory Focus
Hahn Stresses Importance of Data, RWE in First All-Hands Meeting
Previous
